Titre:
  • Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Auteur:Metzger-Filho, Otto; Azambuja, Evandro; Procter, Marion; Krieguer, Magalie; Smith, Ian; Baselga, José; Cameron, David; Untch, Michael; Jackisch, Christian; Bell, Richard; Gianni, Luca; Goldhirsch, Aron; Piccart-Gebhart, Martine; Gelber, Richard
Informations sur la publication:Breast cancer research and treatment, 155, 1, page (127-132)
Statut de publication:Publié, 2016-01
Sujet CREF:Cancérologie
Mots-clés:Breast cancer
Disease-free survival
HER2+
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0167-6806
info:doi/10.1007/s10549-015-3656-0
info:scp/84953357758